Reaction Details Report a problem with these data
Target
E3 ubiquitin-protein ligase parkin
Ligand
BDBM562077
Substrate
n/a
Meas. Tech.
In Vitro Enzyme Activity and Drug Binding
EC50
5000±n/a nM
Citation
 Springer, W; Fiesel, FC; Caulfield, TR Small molecule activators of Parkin enzyme function US Patent  US11401255 Publication Date 8/2/2022 
Target
Name:
E3 ubiquitin-protein ligase parkin
Synonyms:
PARK2 | PRKN | PRKN_HUMAN | Parkin | Parkin RBR E3 ubiquitin-protein ligase | Parkinson disease protein 2 | Parkinson juvenile disease protein 2
Type:
Protein
Mol. Mass.:
51645.70
Organism:
Human
Description:
O60260
Residue:
465
Sequence:
MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV
  
Inhibitor
Name:
BDBM562077
Synonyms:
US11401255, Compound # 11
Type:
Small organic molecule
Emp. Form.:
C22H18N4O
Mol. Mass.:
354.4045
SMILES:
O=C(Cn1ccnc1-c1ccncc1)Nc1ccc(cc1)-c1ccccc1
Structure:
Search PDB for entries with ligand similarity: